Font Size: a A A
Keyword [ACS patients]
Result: 81 - 93 | Page: 5 of 5
81. Expression Level Of PCSK6-soluble Corin-natriuretic Peptide Pathway In ACS Patients And Its Correlation With Coronary Artery Disease Severity And Short-term Prognosis
82. Meta-analysis Of IMD Expression In ACS Patients And Its Relationship With The Extent Of Coronary Artery Lesion
83. Analysis Of Psychological Health Status And Correlation Between Sensitivity Of Interpersonal Relationships And Prognosis Among Patients With Acute Coronary Syndrome
84. Effect Of Early Application Of PCSK9 Inhibitor On Slow/No-reflow During PCI In ACS Patients
85. Correlation Between Neutrophil/lymphocyte Ratio,Red Blood Cell Distribution Width And Prognosis Of ACS Patients With Different TCM Syndromes
86. Effects Of PCSK9 Inhibitors On ACS Patients With Type 2 Diabetes Mellitus After PCI
87. Influence Of Early Left Ventricular Ejection Fraction Change On Prognosis After Initial PCI In ACS Patients With Impaired Left Ventricular Ejection Fraction
88. The Prognostic Value Of TyG Index Combined With NLR In Non-diabetic ACS Patients Treated With Drug-eluting Stents
89. Effect Of Anticoagulant Drug Selection On Short-term Prognosis Of ACS Patients With Different Risk Stratifications During PCI
90. A Meta-Analysis Of Platelet Reactivity With MACE In ACS Patients Post-PCI Under Dual Antiplatelet Therapy
91. Predictive Value Of Platelet Reactivity Tests For Adverse Events In ACS Patients After Discharge
92. The Observation Of The Early Efficacy Of PCSK9 Inhibitors-Evolocumab In Ultra-high-risk ACS Patients
93. The Clinical Study Of Evolocumab In Improving Lipid Metabolism And Carotid Atherosclerosis In ACS Patients With PCI
  <<First  <Prev  Next>  Last>>  Jump to